Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS

University of Ottawa

$5,000.00

The Creation and Analysis of Muscle Progenitor Cells from Patients with Hutchinson-Gilford progeria syndrome

FY 2013-14

Summary
Patients with Hutchison-Gilford Progeria Syndrome (HGPS) exhibit accelerated aging in skeletal muscle, leading to wasting and loss of muscle function. Patients with HGPS generally have a common genetic mutation, which leads to skeletal muscle atrophy. A major barrier to treating human disease is the ability to identify an appropriate model system for studying causative mechanisms. Using a human in vitro model of HGPS would provide a system in which to study the mechanisms regulating skeletal muscle dysfunction. The discovery of induced pluripotent stem cells (iPSCs) allows us to recreate patient-specific tissues in culture, providing an unlimited source of cells. These iPSC are similar to embryonic stem cells, but are derived from adult cells. A major limitation for studying muscle diseases has been the relatively inefficient formation of muscle progenitor cells (MPCs), expressing the adult muscle stem cell (satellite cell) marker Pax7, from iPSCs or human embryonic stem cells. Recently, a method has been developed to differentiate human embryonic stem cells (hESCs) into skeletal muscle, generating a population of MPCs expressing the satellite cell marker Pax7. We propose to apply this differentiation protocol to iPSCs from patients with progeria, who exhibit accelerated muscle atrophy. The patient-derived Pax7+ve MPCs will be characterized for their proliferation and differentiation capacities. Using the iPSC approach, we will generate a model system for detailed analysis of the molecular pathways affected by the disease-causing genetic defect. It will also provide an in vitro disease model system for future drug screens. Finally, understanding the accelerated aging in progeria patients may suggest new approaches to reverse sarcopenia and muscle atrophy. Thus, we will enhance our understanding of the underlying molecular mechanisms causing the chronic disease of Hutchinson-Gilford Progeria, as it relates to skeletal muscle dysfunction.
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
303409
Name
Dimitrova Valeria
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
The Creation and Analysis of Muscle Progenitor Cells from Patients with Hutchinson-Gilford progeria syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Biochemistry; Cell Culture; Genetics; Hutchinson-Gilford Progeria Syndrome; Immunofluorescence; Induced Pluripotent Stem Cells (Ipscs); Qpcr; Skeletal Muscle
Abstract
Patients with Hutchison-Gilford Progeria Syndrome (HGPS) exhibit accelerated aging in skeletal muscle, leading to wasting and loss of muscle function. Patients with HGPS generally have a common genetic mutation, which leads to skeletal muscle atrophy. A major barrier to treating human disease is the ability to identify an appropriate model system for studying causative mechanisms. Using a human in vitro model of HGPS would provide a system in which to study the mechanisms regulating skeletal muscle dysfunction. The discovery of induced pluripotent stem cells (iPSCs) allows us to recreate patient-specific tissues in culture, providing an unlimited source of cells. These iPSC are similar to embryonic stem cells, but are derived from adult cells. A major limitation for studying muscle diseases has been the relatively inefficient formation of muscle progenitor cells (MPCs), expressing the adult muscle stem cell (satellite cell) marker Pax7, from iPSCs or human embryonic stem cells. Recently, a method has been developed to differentiate human embryonic stem cells (hESCs) into skeletal muscle, generating a population of MPCs expressing the satellite cell marker Pax7. We propose to apply this differentiation protocol to iPSCs from patients with progeria, who exhibit accelerated muscle atrophy. The patient-derived Pax7+ve MPCs will be characterized for their proliferation and differentiation capacities. Using the iPSC approach, we will generate a model system for detailed analysis of the molecular pathways affected by the disease-causing genetic defect. It will also provide an in vitro disease model system for future drug screens. Finally, understanding the accelerated aging in progeria patients may suggest new approaches to reverse sarcopenia and muscle atrophy. Thus, we will enhance our understanding of the underlying molecular mechanisms causing the chronic disease of Hutchinson-Gilford Progeria, as it relates to skeletal muscle dysfunction.
Competitiondate
201401
Approvedterm2
0 yr 3 mths
Pinamesdelim
Dimitrova, Valeria
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $5,000~ $0~